LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 106 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $816,156 | -5.8% | 356,400 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $866,052 | +2069.5% | 356,400 | +1605.3% | 0.00% | – |
| Q4 2022 | $39,919 | -92.6% | 20,900 | -90.7% | 0.00% | -100.0% |
| Q3 2022 | $538,203 | +591.1% | 224,336 | +436.7% | 0.00% | – |
| Q2 2022 | $77,874 | -11.2% | 41,800 | 0.0% | 0.00% | – |
| Q1 2022 | $87,681 | -70.4% | 41,800 | -44.4% | 0.00% | -100.0% |
| Q4 2021 | $296,000 | -88.7% | 75,200 | -86.8% | 0.00% | -75.0% |
| Q2 2021 | $2,620,000 | +10.9% | 571,000 | +41.9% | 0.00% | -42.9% |
| Q1 2021 | $2,362,000 | +1008.9% | 402,300 | +546.8% | 0.01% | +600.0% |
| Q4 2020 | $213,000 | +180.3% | 62,200 | +61.1% | 0.00% | – |
| Q1 2020 | $76,000 | -93.2% | 38,600 | -85.7% | 0.00% | -100.0% |
| Q4 2019 | $1,118,000 | +120.9% | 269,404 | +60.4% | 0.00% | +100.0% |
| Q3 2019 | $506,000 | -68.7% | 168,000 | -34.7% | 0.00% | -66.7% |
| Q2 2019 | $1,618,000 | +413.7% | 257,200 | +354.4% | 0.00% | +200.0% |
| Q1 2019 | $315,000 | – | 56,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $14,779,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $243,430,000 | 5.23% |
| BVF INC/IL | 10,963,000 | $37,493,000 | 1.48% |
| Integral Health Asset Management, LLC | 300,000 | $1,026,000 | 0.30% |
| NEA Management Company, LLC | 2,382,286 | $8,147,000 | 0.22% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $122,000 | 0.13% |
| PINNACLE ASSOCIATES LTD | 1,852,382 | $6,335,000 | 0.13% |
| XTX MARKETS LLC | 13,242 | $45,000 | 0.09% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 828,192 | $2,832,000 | 0.06% |
| WINTON GROUP Ltd | 192,890 | $660,000 | 0.05% |